<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02337023</url>
  </required_header>
  <id_info>
    <org_study_id>P101002</org_study_id>
    <nct_id>NCT02337023</nct_id>
  </id_info>
  <brief_title>Brain Scintigraphy in Normal Versus Kleine-Levin Syndrome Subjects</brief_title>
  <acronym>SCINTIK</acronym>
  <official_title>Brain Scintigraphy in Normal Versus Kleine-Levin Syndrome Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators perform neuropsychological tests and brain scintigraphy in 30 healthy&#xD;
      subjects.&#xD;
&#xD;
      These results will be compared with data obtained out of episode in patients with&#xD;
      Kleine-Levin syndrome (KLS).&#xD;
&#xD;
      The investigators want to determine if brain functional imaging and cognitive abnormalities&#xD;
      persist during asymptomatic period in a large series of patients with KLS, and to find&#xD;
      predictors of these abnormalities.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      3 steps in the protocol :&#xD;
&#xD;
        -  Brain ECD-SPECT (marking brain perfusion in relation to brain active/hypoactive area)&#xD;
           superimposed on a template T1-weighted brain MRI.&#xD;
&#xD;
        -  Extensive cognitive tests of executive functions, verbal memory and fluency ,&#xD;
           visuospatial ability and memory, reasoning abilities: spontaneous memory complaint,&#xD;
           Stroop Color Word Test, Trail Making Test A and B, Direct and Reverse Digit Span Test,&#xD;
           Letter and Semantic Fluency Test, Free and Cued Selective Reminding Test, Rey-Osterrieth&#xD;
           Complex Figure, Mini-Mental test, Progressive matrice of Raven (PM-38)&#xD;
&#xD;
        -  KLS-inventory and face to face interview of patients and parents by neurologist for&#xD;
           patients. Modified KLS-inventory for healthy subjects.&#xD;
&#xD;
      Main outcome : Number of patients with persisting hypoperfused brain area (compared to&#xD;
      controls), location of these area, number of patients with at least -1SD in one cognitive&#xD;
      domain Correlation between KLS severity (disease course, number of episode, mean duration of&#xD;
      episodes, time incapacitated, number of symptoms) and brain perfusion and cognitive&#xD;
      abnormalities&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2011</start_date>
  <completion_date type="Actual">May 2015</completion_date>
  <primary_completion_date type="Actual">May 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Crossover</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Brain perfusion.</measure>
    <time_frame>day 0</time_frame>
    <description>Brain perfusion measured by scintigraphy with injection of Neurolite® (ECD) with a voxel by voxel approach</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">56</enrollment>
  <condition>Healthy Subjects</condition>
  <condition>Kleine-Levin Syndrome</condition>
  <arm_group>
    <arm_group_label>healthy subjects</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>patients with Kleine-Levin Syndrome</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Brain scintigraphy with injection of Neurolite® (ECD)</intervention_name>
    <description>Brain scintigraphy with injection of Neurolite® (ECD) 1 injection</description>
    <arm_group_label>healthy subjects</arm_group_label>
    <arm_group_label>patients with Kleine-Levin Syndrome</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy subjects&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria :&#xD;
&#xD;
          -  Subjects males and females with more than 18 y.o, age and sex-matched with patients&#xD;
             with Kleine-Levin Syndrome&#xD;
&#xD;
          -  with the same educational level and dominant hand than patients with Kleine-Levin&#xD;
             Syndrome&#xD;
&#xD;
          -  without any brain disease or sleep disease (Epworth score &lt; 11/24) known.&#xD;
&#xD;
          -  with social security&#xD;
&#xD;
          -  french language&#xD;
&#xD;
          -  for women : nonpregnant taking effective contraception&#xD;
&#xD;
        Exclusion criteria :&#xD;
&#xD;
          -  Minor subjects&#xD;
&#xD;
          -  adults under protection&#xD;
&#xD;
          -  subjects with neurologic, psychiatric, somatic or sleep diseases and/or receiving a&#xD;
             psychotropic medication interfering with the results.&#xD;
&#xD;
          -  subjects with history of seizures or loss of consciousness&#xD;
&#xD;
          -  subjects with excessive alcohol consumption (more than 3 doses /day)&#xD;
&#xD;
          -  subjects without any social security&#xD;
&#xD;
          -  subjects non fluent in french&#xD;
&#xD;
          -  for women : no effective contraception or lactation period&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Isabelle ARNULF, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Groupe Hospitalier Pitié Salpêtrière</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <study_first_submitted>December 5, 2014</study_first_submitted>
  <study_first_submitted_qc>January 8, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 13, 2015</study_first_posted>
  <last_update_submitted>July 20, 2015</last_update_submitted>
  <last_update_submitted_qc>July 20, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 21, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Brain scintigraphy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kleine-Levin Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Technetium Tc 99m bicisate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

